Loading...
NYSE: LH
Labcorp Holdings Inc.
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 2004
Market Cap
$21.85B
52w High
$293.72
52w Low
$209.38
P/E
24.80
Volume
145.89K
Outstanding Shares
82.90M
Company profile
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.
CEOAdam H. Schechter
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees60,900
IPO dateMar 29, 1990
Valuation
Forward P/E—
EV/EBITDA13.69
Enterprise value$27.54B
Stock splits
Jul 3, 2023291:250
May 13, 20022:1
Jun 12, 20012:1
May 4, 20001:10
Profitability & growth
Revenue growth5.6%
Gross margin28.24%▼3.98%vs FY2024
Operating margin10.74%▲30.09%vs FY2024
ROE10.17%▲9.76%vs FY2024
Analyst consensus
RatingBuy
Target price$315.38▲19.68%
26
Buy
9
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$4.35
$4.17
Q3FY25
ActualEst.
$4.18
$4.13
Q4FY25
ActualEst.
$4.07
$3.95
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$3.53B
$3.49B
Q3FY25
ActualEst.
$3.56B
$3.56B
Q4FY25
ActualEst.
$3.52B
$3.56B
Q1FY26
Next Est.
—